Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1166.45
-9.10 (-0.77%)
< Home < Back

Dr.Reddy's Laboratories informs about cessation of CO

Date: 17-03-2022
Dr.Reddy's Laboratories has informed about Cessation of Vivek Mittal as interim Compliance Officer w.e.f. March 17, 2022 on account of appointment of K Randhir Singh as Company Secretary and Compliance Officer. 

The above information is a part of company’s filings submitted to BSE.